Parkinson’s disease affects the brain’s nerve cells that produce dopamine. The symptoms include muscle rigidity, tremors, and changes in speech and gait. Researchers at the University of Helsinki have identified a molecule called BT13 that potentially can increase levels of dopamine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,